fda compounding semaglutide warning november 2025 The Risks of Compounded Products New project announcement: HHS‑OIG is

From this perspective, mild thermal sensations after injection are a sign the drug is working not a warning sign

503A pharmacies compound medications for specific individual patients based on a valid prescription from a licensed prescriber

Ozempic: Key Differences Benefits and Risks Both options offer significant benefits, but it is essential to understand their risks: Ozempic Risks : - Gastrointestinal side effects, such as nausea or diarrhea

Clinical trials have shown that retatrutide can lower HbA1c (a key marker of blood sugar control) by more than 2%, a remarkable improvement compared to many existing treatments

Side-effect context matters for people with diabetes, dehydration risk, kidney disease, gallbladder disease, severe reflux, gastroparesis (delayed stomach emptying), or a history of pancreatitis